Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

---

Publications & Presentations

16. Chang E, Parman A, Johnson P N, Stephens K, Neely S, Dasari N, Kassa N, Miller J L. Gabapentin for Delirium in Infants in the Neonatal Intensive Care Unit. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2024; 29 : 487-493

17. Ropp D L, Johnson P N, Stephens K, Neely S, Chaaban H, Miller J L. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of perinatology : official journal of the California Perinatal Association. 2024; 44 : 1478-1484

18. Foote D, Miller J L, Skrepnek G H, Neely S, Harrison K, Boylan P. Montelukast deprescribing in outpatient specialty clinics: a single center cross-sectional study. Exploratory Research in Clinical and Social Pharmacy. 2024; 17 : 100509

19. Johnson P N, Chang E, Cormack E, Hornaday K, Neely S, Ranallo C, Chaaban H, Garcia-Contreras L, Miller J L. Detectable Concentrations With Inhaled Tobramycin in Critically Ill Infants and Children Following Implementation of Standardized Protocol. The Annals of pharmacotherapy. 2024 : 10600280241282433

20. Flanagan T, Mercer K, Johnson P N, Miller J L, Yousaf F S, Perrine J. Ketamine Use in Adult and Pediatric Patients Receiving Extracorporeal Membrane Oxygenation (ECMO): A Systematic Review. Journal of pharmacy practice. 2024; 37 : 985-994

Grants

1. Selenium Pharmacokinetics and Pharmacodynamics of Infants with Intestinal Failure a Prospective Cohort Study. Misc Non-Federal. Start Date: 2025. End Date: 2026.

2. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

3. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

Awards and Honors

11. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.


12. Rho Chi, Gamma Chapter. 2019 Chapter Alumni Award. Date: 2019.


13. Oklahoma Society of Health-System Pharmacists. Oklahoma Pharmacist of the Year. Date: 2019.


14. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Best Paper Award. Date: 2018.


15. Pediatric Pharmacy Association. Fellow of Pediatric Pharmacy Association. Date: 2018.

Education

1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.


2. Degree: BS. Trevecca Nazarene University. Date: 2002.

Administrative Assignments

1. Role: Department Vice-Chair. Scope: Department. Date: 2021.
Read More